Company Overview of Cambridge Major Laboratories, Inc.
Cambridge Major Laboratories, Inc. develops and manufactures active pharmaceutical ingredients. The company offers a range of outsourcing services from early preclinical stages to post-NDA commercial manufacture to pharmaceutical and biotechnology industries. Its services include solid state chemistry, formulation development, analytical development and testing, clinical and commercial finished dosage form manufacturing (solid dose and parenteral), packaging, and stability. Cambridge Major Laboratories, Inc. was formerly known as Cambridge Chemical Inc. and changed its name to Cambridge Major Laboratories, Inc. in 1999. The company is based in Germantown, Wisconsin with facilities in Europe ...
W130 N10497 Washington Drive
Germantown, WI 53022
Key Executives for Cambridge Major Laboratories, Inc.
Founder, Non-Executive Chairman and Scientific Advisor
Chief Financial Officer and Executive Vice President
Chief Information Officer and Vice President of Information Technology
Compensation as of Fiscal Year 2014.
Cambridge Major Laboratories, Inc. Key Developments
Cambridge Major Laboratories Inc. Announces More Than $20 Million Expansion of its Germantown Facility
Dec 17 14
Cambridge Major Laboratories Inc. has received an incentive package from state and local governments worth as much as $2 million as part of a more than $20 million expansion of its Germantown facility. The expansion is expected to create more than 75 jobs during the next three years. Cambridge Major's expansion will include a new administrative headquarters, as well as additions to its research and development and manufacturing capacity. The expansion is scheduled to be completed by the end of 2015.
Cambridge Major Laboratories Appoints Marcel Schreuder Goedheijt as General Manager, Cambridge Major Laboratories, Inc.'s Europe
Sep 30 14
AAIPharma Services Corp. and Cambridge Major Laboratories, Inc. announced the appointment of Marcel Schreuder Goedheijt, Ph.D. as General Manager, Cambridge Major Laboratories, Europe. In this role, Marcel is responsible for directing the day to day business activities as a leading global service-based chemistry outsourcing partner to the pharmaceutical and biotechnology industries - producing pharmaceutical intermediates, API's and other fine organic chemicals. With over 15 years of experience in the chemical and pharmaceutical industries, Dr. Schreuder Goedheijt has held leadership positions at DSM Pharma Chemicals, MSD (Organon) and Diosynth.
AAIPharma Services Corp. and Cambridge Major Laboratories, Inc. Appoint Stephan Kutzer as Chief Executive Officer, Effective August 1, 2014
Jul 8 14
AAIPharma Services Corp. and Cambridge Major Laboratories, Inc. announced the appointment of Stephan Kutzer, Ph.D. as Chief Executive Officer (CEO), effective August 1, 2014. Most recently, Dr. Kutzer served as Chief Operating Officer of Lonza Inc. Since 2003, he has also served as Chief Operating Officer and/or President of several divisions, including Lonza Pharma Biotech Division, Lonza Custom Manufacturing, Lonza Biopharmaceuticals and Lonza Performance Chemicals.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|